Psychiatry - November 2008 - (Page 48)

[the interface] 8. 9. 10. 11. 12. 13. 14. cardiovascular mortality differences within Hungary. J Epidemiol Community Health. 2006;60:782–788. Gromova HA, Gafarov VV, Gagulin IV. Depression and risk of cardiovascular diseases among males aged 25–64 (WHO MONICA— psychosocial). Alaska Med. 2006;49:255–258. Boulware LE, Liu Y, Fink NE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol. 2006;1:496–504. de Jonge P, van den Brink RH, Spijkerman TA, Ormel J. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol. 2006;48:2204–2208. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch Gen Psychiatry. 2006;63:874–880. Jaffe AS, Krumholz HM, Catellier DJ, et al. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J. 2006;152:126–135. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Int Med. 2007;167:367–373. Garcia-Gomez RG, Lopez-Jaramillo P, Tomaz C. The role played by the autonomic nervous system in the relation between depression and cardiovascular disease. Rev Neurol. 2007;44:225–233. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. Bounhoure JP, Galinier M, Curnier D, et al. Influence of depression on the prognosis of cardiovascular diseases. Bull Acad Natl Med. 2006;190:1723–1731. Fenton WS, Stover ES. Mood disorders: cardiovascular and diabetes comorbidity. Curr Opin Psychiatry. 2006;19:421–427. Parissis JY, Fountoulaki K, Filippatos G, et al. Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications. Int J Cardiol. 2007;116:153–160. Carroll D, Phillips AC, Hunt K, Der G. Symptoms of depression and cardiovascular reactions to acute psychological stress: evidence from a population study. Biol Psychol. 2007;75:68–74. York KM, Hassan M, Li Q, et al. Coronary artery disease and depression: patients with more depressive symptoms have lower cardiovascular reactivity during laboratory-induced mental stress. Psychosom Med. 2007;69:521–528. Whooley MA, Caska CM, Hendrickson BE, et al. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry. 2007;62:314–320. Kamphuis MH, Geerlings MI, Tijhuis MA, et al. Physical inactivity, depression, and risk of cardiovascular mortality. Med Sci Sports Exerc. 2007;39:1693–1699. Spernak SM, Moore PJ, Hamm LF. Depression, constructive thinking and patient satisfaction in cardiac treatment adherence. Psychol Health Med. 2007;12:172–189. Rivelli S, Jiang W. Depression and ischemic heart disease: What have we learned from clinical trials? Curr Opin Cardiol. 2007;22:286–291. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295:2874–2881. 25. 26. 27. 28. lassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709. de Jonge P, Honig A, van Melle JP, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry. 2007;164:1371–1378. Mohapatra PK, Kar N, Kar GC, Behera M. Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Pract Epidemiol Ment Health. 2005;1:26. Paraskevaidis I, Parissis JT, Fountoulaki K, et al. Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effects. Cardiovasc Hematol Agents Med Chem. 2006;4:361–367. AUTHOR AFFILIATIONS: Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a family medicine physician (government service) and Medical Director of the Primary Care Clinic at Wright-Patterson Air Force Base. The views and opinions expressed in this column are those of the authors and do not reflect the official policy or the position of the United States Air Force, Department of Defense, or US government. ADDRESS CORRESPONDENCE TO: Randy A. Sansone, MD, Sycamore Primary Care Center, 2115 Leiter Road, Miamisburg, OH 45342; Phone: (937) 384-6850; Fax: (937) 384-6938; E-mail: Randy.sansone@khnetwork.org 48 Psychiatry 2008 [ N O V E M B E R ]

Table of Contents Feed for the Digital Edition of Psychiatry - November 2008

Psychiatry - November 2008 Editor's Message Editorial Advisory Board Contents PsychRx Letters to the Editor Measuring Adverse Events in Psychiatry Nonsuicidal Self Injury in Adolescents Relative Tolerability of Alzheimer's Disease Treatments Biracial Identity Development and Recommendations in Therapy Depression and Cardiovascular Disease: Just an Urban Legend? Three Risk Management Basics Journal Watch Classified Advertising Information for Authors

Psychiatry - November 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.